A comparative approach of the past and present of malignant external otitis treatment on diabetic patients with quinolones

Authors

  • Lucía R. Carnegie Squires
  • Ibis M. Figueras Hechavarría
  • Eleazar Bueno González
  • Carlos A. Savigne Jones

Keywords:

malignant external otitis, diabetes mellitus, osteomielitis

Abstract

A study is performed on diabetic patients with malignant external otitis in the Department of Otolaryngology, at the General Teaching Hospital Dr Agostinho Neto from 1990 to2013, inorder to compare results before and after incorporationof quinolone treatment. The universe consisted of 45 patients: 25 Group I, from 1990 to 2000, treated with conventionalantibiotics and 20 Group II, from 2001 to 2013, receiving quinolones. The variables studied were: age, sex, type ofdiabetes, clinical, admission glycemia, bacteriology, treatment, among others. In Group I prevailed night and intense pain; the combination of beta-lactam was used - aminoglycosides, many patients had a hospital stay between 31 and 40 days. In group II the pain was less intense and endurable, quinolone was used in 80 % and in 12 patients, the stay wasless than 10 days. A. Pseudomonas was isolated in 75.5 % of cultures. The use of quinolones had a great impact on patients, since the reduction of pain, reversal of the clinical symptoms; absence of complications and reduced of hospital stay.

Downloads

Download data is not yet available.

How to Cite

1.
Carnegie Squires LR, Figueras Hechavarría IM, Bueno González E, Savigne Jones CA. A comparative approach of the past and present of malignant external otitis treatment on diabetic patients with quinolones. Rev Inf Cient [Internet]. 2015 Feb. 18 [cited 2025 Apr. 13];90(2):289-300. Available from: https://revinfcientifica.sld.cu/index.php/ric/article/view/248

Issue

Section

Original Articles